Literature DB >> 31104771

Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.

Galen E B Wright1, Jennifer A Collins1, Chris Kay1, Cassandra McDonald1, Egor Dolzhenko2, Qingwen Xia1, Kristina Bečanović3, Britt I Drögemöller4, Alicia Semaka5, Charlotte M Nguyen6, Brett Trost7, Fiona Richards8, Emilia K Bijlsma9, Ferdinando Squitieri10, Colin J D Ross4, Stephen W Scherer11, Michael A Eberle2, Ryan K C Yuen6, Michael R Hayden12.   

Abstract

Huntington disease (HD) is caused by a CAG repeat expansion in the huntingtin (HTT) gene. Although the length of this repeat is inversely correlated with age of onset (AOO), it does not fully explain the variability in AOO. We assessed the sequence downstream of the CAG repeat in HTT [reference: (CAG)n-CAA-CAG], since variants within this region have been previously described, but no study of AOO has been performed. These analyses identified a variant that results in complete loss of interrupting (LOI) adenine nucleotides in this region [(CAG)n-CAG-CAG]. Analysis of multiple HD pedigrees showed that this LOI variant is associated with dramatically earlier AOO (average of 25 years) despite the same polyglutamine length as in individuals with the interrupting penultimate CAA codon. This LOI allele is particularly frequent in persons with reduced penetrance alleles who manifest with HD and increases the likelihood of presenting clinically with HD with a CAG of 36-39 repeats. Further, we show that the LOI variant is associated with increased somatic repeat instability, highlighting this as a significant driver of this effect. These findings indicate that the number of uninterrupted CAG repeats, which is lengthened by the LOI, is the most significant contributor to AOO of HD and is more significant than polyglutamine length, which is not altered in these individuals. In addition, we identified another variant in this region, where the CAA-CAG sequence is duplicated, which was associated with later AOO. Identification of these cis-acting modifiers have potentially important implications for genetic counselling in HD-affected families.
Copyright © 2019 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAG repeat; Huntington disease; age of onset; genetic modifier; loss of interruption; polyglutamine; reduced penetrance alleles; somatic instability

Year:  2019        PMID: 31104771      PMCID: PMC6556907          DOI: 10.1016/j.ajhg.2019.04.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles.

Authors:  A Maat-Kievit; M Losekoot; H Van Den Boer-Van Den Berg; G J Van Ommen; M Niermeijer; M Breuning; A Tibben
Journal:  J Med Genet       Date:  2001-04       Impact factor: 6.318

2.  Familial influence on age of onset among siblings with Huntington disease.

Authors:  A Rosenblatt; R R Brinkman; K Y Liang; E W Almqvist; R L Margolis; C Y Huang; M Sherr; M L Franz; M H Abbott; M R Hayden; C A Ross
Journal:  Am J Med Genet       Date:  2001-07-08

3.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.

Authors:  K Nakamura; S Y Jeong; T Uchihara; M Anno; K Nagashima; T Nagashima; S Ikeda; S Tsuji; I Kanazawa
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

4.  Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.

Authors:  L C Williams; M R Hegde; R Nagappan; R L Faull; J Giles; I Winship; K Snow; D R Love
Journal:  Genet Test       Date:  2000

5.  CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.

Authors:  H Fujigasaki; J J Martin; P P De Deyn; A Camuzat; D Deffond; G Stevanin; B Dermaut; C Van Broeckhoven; A Dürr; A Brice
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

6.  An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia.

Authors:  S Costanzi-Porrini; D Tessarolo; C Abbruzzese; M Liguori; T Ashizawa; M Giacanelli
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

7.  Polymorphisms in the CAG repeat--a source of error in Huntington disease DNA testing.

Authors:  S Yu; A Fimmel; D Fung; R J Trent
Journal:  Clin Genet       Date:  2000-12       Impact factor: 4.438

8.  Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

Authors:  Laura Kennedy; Elizabeth Evans; Chiung-Mei Chen; Lyndsey Craven; Peter J Detloff; Margaret Ennis; Peggy F Shelbourne
Journal:  Hum Mol Genet       Date:  2003-10-21       Impact factor: 6.150

9.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  47 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

2.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

Review 3.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

4.  Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.

Authors:  Bohu Pan; Luyao Ren; Vitor Onuchic; Meijian Guan; Rebecca Kusko; Steve Bruinsma; Len Trigg; Andreas Scherer; Baitang Ning; Chaoyang Zhang; Christine Glidewell-Kenney; Chunlin Xiao; Eric Donaldson; Fritz J Sedlazeck; Gary Schroth; Gokhan Yavas; Haiying Grunenwald; Haodong Chen; Heather Meinholz; Joe Meehan; Jing Wang; Jingcheng Yang; Jonathan Foox; Jun Shang; Kelci Miclaus; Lianhua Dong; Leming Shi; Marghoob Mohiyuddin; Mehdi Pirooznia; Ping Gong; Rooz Golshani; Russ Wolfinger; Samir Lababidi; Sayed Mohammad Ebrahim Sahraeian; Steve Sherry; Tao Han; Tao Chen; Tieliu Shi; Wanwan Hou; Weigong Ge; Wen Zou; Wenjing Guo; Wenjun Bao; Wenzhong Xiao; Xiaohui Fan; Yoichi Gondo; Ying Yu; Yongmei Zhao; Zhenqiang Su; Zhichao Liu; Weida Tong; Wenming Xiao; Justin M Zook; Yuanting Zheng; Huixiao Hong
Journal:  Genome Biol       Date:  2022-01-03       Impact factor: 13.583

5.  Age of Onset of Huntington's Disease in Carriers of Reduced Penetrance Alleles.

Authors:  Erin I McDonnell; Yuanjia Wang; Jill Goldman; Karen Marder
Journal:  Mov Disord       Date:  2021-09-18       Impact factor: 10.338

6.  Human-specific tandem repeat expansion and differential gene expression during primate evolution.

Authors:  Arvis Sulovari; Ruiyang Li; Peter A Audano; David Porubsky; Mitchell R Vollger; Glennis A Logsdon; Wesley C Warren; Alex A Pollen; Mark J P Chaisson; Evan E Eichler
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-28       Impact factor: 11.205

7.  Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice.

Authors:  Amrutha Pattamatta; Lien Nguyen; Hailey R Olafson; Marina M Scotti; Lauren A Laboissonniere; Jared Richardson; J Andrew Berglund; Tao Zu; Eric T Wang; Laura P W Ranum
Journal:  Hum Mol Genet       Date:  2021-02-25       Impact factor: 6.150

8.  Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.

Authors:  Branduff McAllister; James F Gusella; G Bernhard Landwehrmeyer; Jong-Min Lee; Marcy E MacDonald; Michael Orth; Anne E Rosser; Nigel M Williams; Peter Holmans; Lesley Jones; Thomas H Massey
Journal:  Neurology       Date:  2021-03-25       Impact factor: 11.800

9.  Propensity for somatic expansion increases over the course of life in Huntington disease.

Authors:  Radhia Kacher; François-Xavier Lejeune; Sandrine Noël; Cécile Cazeneuve; Alexis Brice; Sandrine Humbert; Alexandra Durr
Journal:  Elife       Date:  2021-05-13       Impact factor: 8.140

Review 10.  Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.

Authors:  Sarah J Tabrizi; Michael D Flower; Christopher A Ross; Edward J Wild
Journal:  Nat Rev Neurol       Date:  2020-08-14       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.